Functional role and mechanisms of sialyllactose and other sialylated milk oligosaccharides

Nutrition Reviews

Volumn 72, Issue 6, 2014, Pages 377-389

  Ten Bruggencate, Sandra Jm ^a   Bovee Oudenhoven, Ingeborg Mj ^b   Feitsma, Anouk L ^b   van Hoffen, Els ^a   Schoterman, Margriet Hc ^b  

^a NIZO FOOD RESEARCH   (Netherlands)

^b FRIESLANDCAMPINA   (Netherlands)

Author keywords

Breast milk; Health effects; Human milk oligosaccharides; Infant; Milk; Sialic acid; Sialylated oligosaccharides; Sialyllactose

Indexed keywords

GALACTOSE; LACTOSE; N ACETYLGLUCOSAMINE; NEURAMINIC ACID; OLIGOSACCHARIDE; SIALIC ACID DERIVATIVE; SIALYLLACTOSE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL MILK; BACTEROIDES; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM LONGUM; BRAIN DEVELOPMENT; BREAST MILK; CATTLE; COGNITIVE DEVELOPMENT; DIGESTION; ENDOCYTOSIS; GASTROINTESTINAL ABSORPTION; HUMAN; INFANT NUTRITION; INFLAMMATORY BOWEL DISEASE; INFLUENZA; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACTATION; LOWER RESPIRATORY TRACT INFECTION; NECROTIZING ENTEROCOLITIS; NONHUMAN; PINOCYTOSIS; PREGNANCY; PREMATURE LABOR; STREPTOCOCCUS PNEUMONIAE; UPPER GASTROINTESTINAL TRACT; VIRAL RESPIRATORY TRACT INFECTION;

BREAST MILK; HEALTH EFFECTS; HUMAN MILK OLIGOSACCHARIDES; INFANT; MILK; SIALIC ACID; SIALYLATED OLIGOSACCHARIDES; SIALYLLACTOSE;

ANIMALS; BREAST FEEDING; DIET; DIETARY SUPPLEMENTS; GASTROINTESTINAL TRACT; HUMANS; INFANT; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; LACTOSE; MILK, HUMAN; NUTRITIONAL REQUIREMENTS; OLIGOSACCHARIDES; SIALIC ACIDS;

EID: 84901821773     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12106     Document Type: Article

References (169)

1. Bode L. Human milk oligosaccharides: prebiotics and beyond. Nutr Rev. 2009;67(Suppl 2):S183-S191.
2. Ronnestad A, Abrahamsen TG, Medbo S, etal. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics. 2005;115:e269-e276.
3. Leung AK, Sauve RS. Breast is best for babies. J Natl Med Assoc. 2005;97:1010-1019.
4. Hoddinott P, Tappin D, Wright C. Breast feeding. BMJ. 2008;336:881-887.
5. Adlerberth I. Factors influencing the establishment of the intestinal microbiota in infancy. Nestle Nutr Workshop Ser Pediatr Program. 2008;62:13-29; discussion 29-33.
6. Arslanoglu S, Moro GE, Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr. 2007;137:2420-2424.
7. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr. 2005;25:37-58.
8. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401-1412.
9. Ben XM, Li J, Feng ZT, etal. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World J Gastroenterol. 2008;14:6564-6568.
10. Moro G, Arslanoglu S, Stahl B, etal. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91:814-819.
11. Kunz C, Rudloff S, Baier W, etal. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr. 2000;20:699-722.
12. Boehm G, Stahl B. Oligosaccharides from milk. J Nutr. 2007;137(Suppl 2):847S-849S.
13. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:731-747.
14. McVeagh P, Miller JB. Human milk oligosaccharides: only the breast. J Paediatr Child Health. 1997;33:281-286.
15. Urashima T, Saito T, Nakamura T, etal. Oligosaccharides of milk and colostrum in non-human mammals. Glycoconj J. 2001;18:357-371.
16. Urashima T, Odaka G, Asakuma S, etal. Chemical characterization of oligosaccharides in chimpanzee, bonobo, gorilla, orangutan, and siamang milk or colostrum. Glycobiology. 2009;19:499-508.
17. Chaturvedi P, Warren CD, Altaye M, etal. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology. 2001;11:365-372.
18. Coppa GV, Pierani P, Zampini L, etal. Oligosaccharides in human milk during different phases of lactation. Acta Paediatr Suppl. 1999;88:89-94.
19. Ninonuevo MR, Park Y, Yin H, etal. A strategy for annotating the human milk glycome. J Agric Food Chem. 2006;54:7471-7480.
20. Thurl S, Munzert M, Henker J, etal. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br J Nutr. 2010;104:1261-1271.
21. Tao N, DePeters EJ, Freeman S, etal. Bovine milk glycome. J Dairy Sci. 2008;91:3768-3778.
22. Sundekilde UK, Barile D, Meyrand M, etal. Natural variability in bovine milk oligosaccharides from Danish Jersey and Holstein-Friesian breeds. J Agric Food Chem. 2012;60:6188-6196.
23. Aldredge DL, Geronimo MR, Hua S, etal. Annotation and structural elucidation of bovine milk oligosaccharides and determination of novel fucosylated structures. Glycobiology. 2013;23:664-676.
24. Wang B. Sialic acid is an essential nutrient for brain development and cognition. Annu Rev Nutr. 2009;29:177-222.
25. Wang B, Brand-Miller J. The role and potential of sialic acid in human nutrition. Eur J Clin Nutr. 2003;57:1351-1369.
26. Rudloff S, Kunz C. Protein and nonprotein nitrogen components in human milk, bovine milk, and infant formula: quantitative and qualitative aspects in infant nutrition. J Pediatr Gastroenterol Nutr. 1997;24:328-344.
27. Coppa GV, Gabrielli O, Pierani P, etal. Changes in carbohydrate composition in human milk over 4 months of lactation. Pediatrics. 1993;91:637-641.
28. Kunz C, Rudloff S. Biological functions of oligosaccharides in human milk. Acta Paediatr. 1993;82:903-912.
29. Viverge D, Grimmonprez L, Cassanas G, etal. Variations of lactose and oligosaccharides in milk from women of blood types secretor A or H, secretor Lewis, and secretor H/nonsecretor Lewis during the course of lactation. Ann Nutr Metab. 1985;29:1-11.
30. Neeser JR, Golliard M, Del Vedovo S. Quantitative determination of complex carbohydrates in bovine milk and in milk-based infant formulas. J Dairy Sci. 1991;74:2860-2871.
31. Urashima T, Kitaoka M, Terabayashi T, etal. Milk oligosaccharides. In: Gordon NS, ed. Oligosaccharides: Sources, Properties and Applictions. Hauppauge, NY: Nova Science Publishers, Inc; 2011:1-58.
32. Martin-Sosa S, Martin MJ, Garcia-Pardo LA, etal. Sialyloligosaccharides in human and bovine milk and in infant formulas: variations with the progression of lactation. J Dairy Sci. 2003;86:52-59.
33. Wang B, Brand-Miller J, McVeagh P, etal. Concentration and distribution of sialic acid in human milk and infant formulas. Am J Clin Nutr. 2001;74:510-515.
34. Qiao Y, Feng J, Yang J, etal. The relationship between dietary vitamin A intake and the levels of sialic acid in the breast milk of lactating women. J Nutr Sci Vitaminol (Tokyo). 2013;59:347-351.
35. Carlson SE. N-acetylneuraminic acid concentrations in human milk oligosaccharides and glycoproteins during lactation. Am J Clin Nutr. 1985;41:720-726.
36. Spichtig V, Michaud J, Austin S. Determination of sialic acids in milks and milk-based products. Anal Biochem. 2010;405:28-40.
37. Martin MJ, Martin-Sosa S, Garcia-Pardo LA, etal. Distribution of bovine milk sialoglycoconjugates during lactation. J Dairy Sci. 2001;84:995-1000.
38. Sanchez-Diaz A, Ruano MJ, Lorente F, etal. A critical analysis of total sialic acid and sialoglycoconjugate contents of bovine milk-based infant formulas. J Pediatr Gastroenterol Nutr. 1997;24:405-410.
39. McJarrow P, van Amelsfort-Schoonbeek J. Bovine sialyl oligosaccharides: seasonal variations in their concentrations in milk, and a comparison of the colostrums of Jersey and Friesian cows. Int Dairy J. 2004;14:571-579.
40. Veh RW, Michalski JC, Corfield AP, etal. New chromatographic system for the rapid analysis and preparation of colostrum sialyloligosaccharides. J Chromatogr. 1981;212:313-322.
41. Nakamura T, Kawase H, Kimura K, etal. Concentrations of sialyloligosaccharides in bovine colostrum and milk during the prepartum and early lactation. J Dairy Sci. 2003;86:1315-1320.
42. Fong B, Ma K, McJarrow P. Quantification of bovine milk oligosaccharides using liquid chromatography-selected reaction monitoring-mass spectrometry. J Agric Food Chem. 2011;59:9788-9795.
43. Gopal PK, Gill HS. Oligosaccharides and glycoconjugates in bovine milk and colostrum. Br J Nutr. 2000;84(Suppl 1):S69-S74.
44. Asakuma S, Akahori M, Kimura K, etal. Sialyl oligosaccharides of human colostrum: changes in concentration during the first three days of lactation. Biosci Biotechnol Biochem. 2007;71:1447-1451.
45. Bao Y, Zhu L, Newburg DS. Simultaneous quantification of sialyloligosaccharides from human milk by capillary electrophoresis. Anal Biochem. 2007;370:206-214.
46. Wang B, McVeagh P, Petocz P, etal. Brain ganglioside and glycoprotein sialic acid in breastfed compared with formula-fed infants. Am J Clin Nutr. 2003;78:1024-1029.
47. Wang B, Miller JB, Sun Y, etal. A longitudinal study of salivary sialic acid in preterm infants: comparison of human milk-fed versus formula-fed infants. J Pediatr. 2001;138:914-916.
48. Duncan PI, Raymond F, Fuerholz A, etal. Sialic acid utilisation and synthesis in the neonatal rat revisited. PLoS ONE. 2009;4:e8241. doi: 10.1371/journal.pone.0008241.
49. Viverge D, Grimmonprez L, Cassanas G, etal. Discriminant carbohydrate components of human milk according to donor secretor types. J Pediatr Gastroenterol Nutr. 1990;11:365-370.
50. Kunz C, Rudloff S. Potential anti-inflammatory and anti-infectious effects of human milk oligosaccharides. Adv Exp Med Biol. 2008;606:455-465.
51. Nakano T, Sugawara M, Kawakami H. Sialic acid in human milk: composition and functions. Acta Paediatr Taiwan. 2001;42:11-17.
52. Brand-Miller JC, McVeagh P, McNeil Y, etal. Digestion of human milk oligosaccharides by healthy infants evaluated by the lactulose hydrogen breath test. J Pediatr. 1998;133:95-98.
53. Newburg DS. Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr. 2000;30(Suppl 2):S8-S17.
54. Gnoth MJ, Kunz C, Kinne-Saffran E, etal. Human milk oligosaccharides are minimally digested in vitro. J Nutr. 2000;130:3014-3020.
55. Nohle U, Schauer R. Metabolism of sialic acids from exogenously administered sialyllactose and mucin in mouse and rat. Hoppe Seylers Z Physiol Chem. 1984;365:1457-1467.
56. Engfer MB, Stahl B, Finke B, etal. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr. 2000;71:1589-1596.
57. Dickson JJ, Messer M. Intestinal neuraminidase activity of suckling rats and other mammals. Relationship to the sialic acid content of milk. Biochem J. 1978;170:407-413.
58. Coppa GV, Pierani P, Zampini L, etal. Characterization of oligosaccharides in milk and feces of breast-fed infants by high-performance anion-exchange chromatography. Adv Exp Med Biol. 2001;501:307-314.
59. Sabharwal H, Sjoblad S, Lundblad A. Sialylated oligosaccharides in human milk and feces of preterm, full-term, and weaning infants. J Pediatr Gastroenterol Nutr. 1991;12:480-484.
60. Albrecht S, Schols HA, van den Heuvel EG, etal. CE-LIF-MS n profiling of oligosaccharides in human milk and feces of breast-fed babies. Electrophoresis. 2010;31:1264-1273.
61. Gnoth MJ, Rudloff S, Kunz C, etal. Investigations of the in vitro transport of human milk oligosaccharides by a Caco-2 monolayer using a novel high performance liquid chromatography-mass spectrometry technique. J Biol Chem. 2001;276:34363-34370.
62. Jantscher-Krenn E, Marx C, Bode L. Human milk oligosaccharides are differentially metabolised in neonatal rats. Br J Nutr. 2013;110:640-650.
63. Rudloff S, Pohlentz G, Borsch C, etal. Urinary excretion of in vivo (13)C-labelled milk oligosaccharides in breastfed infants. Br J Nutr. 2012;107:957-963.
64. Coppa GV, Gabrielli O, Giorgi P, etal. Preliminary study of breastfeeding and bacterial adhesion to uroepithelial cells. Lancet. 1990;335:569-571.
65. Rudloff S, Pohlentz G, Diekmann L, etal. Urinary excretion of lactose and oligosaccharides in preterm infants fed human milk or infant formula. Acta Paediatr. 1996;85:598-603.
66. Obermeier S, Rudloff S, Pohlentz G, etal. Secretion of 13C-labelled oligosaccharides into human milk and infant's urine after an oral [13C]galactose load. Isotopes Environ Health Stud. 1999;35:119-125.
67. Tram TH, Brand Miller JC, McNeil Y, etal. Sialic acid content of infant saliva: comparison of breast fed with formula fed infants. Arch Dis Child. 1997;77:315-318.
68. Kolling G, Wu M, Guerrant RL. Enteric pathogens through life stages. Front Cell Infect Microbiol. 2012;2:114. doi: 10.3389/fcimb.2012.00114.
69. Vester Boler BM, Rossoni Serao MC, Faber TA, etal. In vitro fermentation characteristics of select nondigestible oligosaccharides by infant fecal inocula. J Agric Food Chem. 2013;61:2109-2119.
70. Wolin MJ, Miller TL, Yerry S, etal. Changes of fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon. Appl Environ Microbiol. 1999;65:2807-2812.
71. Backhed F, Ley RE, Sonnenburg JL, etal. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915-1920.
72. Stoddart LA, Smith NJ, Milligan G. International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol Rev. 2008;60:405-417.
73. Wong JM, de Souza R, Kendall CW, etal. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235-243.
74. Ward RE, Ninonuevo M, Mills DA, etal. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res. 2007;51:1398-1405.
75. Sela DA, Chapman J, Adeuya A, etal. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A. 2008;105:18964-18969.
76. Yu ZT, Chen C, Newburg DS. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology. 2013;23:1281-1292.
77. Ruiz-Moyano S, Totten SM, Garrido DA, etal. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Appl Environ Microbiol. 2013;79:6040-6049.
78. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004;28:405-440.
79. Lievin V, Peiffer I, Hudault S, etal. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut. 2000;47:646-652.
80. Hart AL, Lammers K, Brigidi P, etal. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut. 2004;53:1602-1609.
81. Favier CF, de Vos WM, Akkermans AD. Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe. 2003;9:219-229.
82. LoCascio RG, Ninonuevo MR, Freeman SL, etal. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem. 2007;55:8914-8919.
83. Sela DA, Li Y, Lerno L, etal. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J Biol Chem. 2011;286:11909-11918.
84. Kavanaugh DW, O'Callaghan J, Butto LF, etal. Exposure of Bifidobacterium longum subsp. infantis to milk oligosaccharides increases adhesion to epithelial cells and induces a substantial transcriptional response. PLoS ONE. 2013;8:e67224. doi: 10.1371/journal.pone.0067224.
85. Kiyohara M, Tanigawa K, Chaiwangsri T, etal. An exo-α-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. Glycobiology. 2011;21:437-447.
86. Brown WR. Relationships between immunoglobulins and the intestinal epithelium. Gastroenterology. 1978;75:129-138.
87. Gill RK, Mahmood S, Nagpaul JP, etal. Functional role of sialic acid in IgG binding to microvillus membranes in neonatal rat intestine. Biol Neonate. 1999;76:55-64.
88. Chu SH, Walker WA. Developmental changes in the activities of sialyl- and fucosyltransferases in rat small intestine. Biochim Biophys Acta. 1986;883:496-500.
89. a antigen of α2, 6-sialyltransferase activity towards N-acetyl-lactosamine. Biochem J. 1990;270:519-524.
90. Donovan SM. Human milk oligosaccharides - the plot thickens. Br J Nutr. 2009;101:1267-1269.
91. Kawashima N, Yoon SJ, Itoh K, etal. Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions. J Biol Chem. 2009;284:6147-6155.
92. Dvorak B. Milk epidermal growth factor and gut protection. J Pediatr. 2010;156(Suppl):S31-S35.
93. Lozano R, Naghavi M, Foreman K, etal. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128.
94. Lane JA, Marino K, Naughton J, etal. Anti-infective bovine colostrum oligosaccharides: Campylobacter jejuni as a case study. Int J Food Microbiol. 2012;157:182-188.
95. Sakarya S, Gokturk C, Ozturk T, etal. Sialic acid is required for nonspecific adherence of Salmonella enterica ssp. enterica serovar Typhi on Caco-2 cells. FEMS Immunol Med Microbiol. 2010;58:330-335.
96. Coppa GV, Zampini L, Galeazzi T, etal. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res. 2006;59:377-382.
97. Finlay BB, Fry J, Rock EP, etal. Passage of Salmonella through polarized epithelial cells: role of the host and bacterium. J Cell Sci Suppl. 1989;11:99-107.
98. Salcedo J, Barbera R, Matencio E, etal. Gangliosides and sialic acid effects upon newborn pathogenic bacteria adhesion: an in vitro study. Food Chem. 2013;136:726-734.
99. Martin-Sosa S, Martin MJ, Hueso P. The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. J Nutr. 2002;132:3067-3072.
100. Schwertmann A, Schroten H, Hacker J, etal. S-fimbriae from Escherichia coli bind to soluble glycoproteins from human milk. J Pediatr Gastroenterol Nutr. 1999;28:257-263.
101. Angeloni S, Ridet JL, Kusy N, etal. Glycoprofiling with micro-arrays of glycoconjugates and lectins. Glycobiology. 2005;15:31-41.
102. Burger O, Weiss E, Sharon N, etal. Inhibition of Helicobacter pylori adhesion to human gastric mucus by a high-molecular-weight constituent of cranberry juice. Crit Rev Food Sci Nutr. 2002;42:279-284.
103. Evans DG, Evans DJ, Jr, Moulds JJ, etal. N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun. 1988;56:2896-2906.
104. Simon PM, Goode PL, Mobasseri A, etal. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun. 1997;65:750-757.
105. Unemo M, Aspholm-Hurtig M, Ilver D, etal. The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. J Biol Chem. 2005;280:15390-15397.
106. Mahajan S, Rodgers FG. Isolation, characterization, and host-cell-binding properties of a cytotoxin from Campylobacter jejuni. J Clin Microbiol. 1990;28:1314-1320.
107. Koketsu M, Nitoda T, Sugino H, etal. Synthesis of a novel sialic acid derivative (sialylphospholipid) as an antirotaviral agent. J Med Chem. 1997;40:3332-3335.
108. Takahashi K, Ohashi K, Abe Y, etal. Protective efficacy of a sulfated sialyl lipid (NMSO3) against human rotavirus-induced diarrhea in a mouse model. Antimicrob Agents Chemother. 2002;46:420-424.
109. Yang JC, Shun CT, Chien CT, etal. Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice. J Nutr. 2008;138:2084-2090.
110. Newburg DS, Peterson JA, Ruiz-Palacios GM, etal. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet. 1998;351:1160-1164.
111. Yolken RH, Peterson JA, Vonderfecht SL, etal. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest. 1992;90:1984-1991.
112. Idota T, Kawakami H, Murakami Y, etal. Inhibition of cholera toxin by human milk fractions and sialyllactose. Biosci Biotechnol Biochem. 1995;59:417-419.
113. Noguchi S, Malicdan MC, Nishino I. Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds. Brain Nerve. 2010;62:601-607.
114. Mysore JV, Wigginton T, Simon PM, etal. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology. 1999;117:1316-1325.
115. Hester SN, Chen X, Li M, etal. Human milk oligosaccharides inhibit rotavirus infectivity in vitro and in acutely infected piglets. Br J Nutr. 2013;110:1233-1242.
116. Opekun AR, El-Zaimaity HM, Osato MS, etal. Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther. 1999;13:35-42.
117. Parente F, Cucino C, Anderloni A, etal. Treatment of Helicobacter pylori infection using a novel antiadhesion compound (3′sialyllactose sodium salt). A double blind, placebo-controlled clinical study. Helicobacter. 2003;8:252-256.
118. Rasko DA, Wilson TJ, Zopf D, etal. Lewis antigen expression and stability in Helicobacter pylori isolated from serial gastric biopsies. J Infect Dis. 2000;181:1089-1095.
119. Bryce J, Boschi-Pinto C, Shibuya K, etal. WHO estimates of the causes of death in children. Lancet. 2005;365:1147-1152.
120. O'Brien KL, Wolfson LJ, Watt JP, etal. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893-902.
121. Van Woensel JB, van Aalderen WM, Kimpen JL. Viral lower respiratory tract infection in infants and young children. BMJ. 2003;327:36-40.
122. Tarrant M, Kwok MK, Lam TH, etal. Breast-feeding and childhood hospitalizations for infections. Epidemiology. 2010;21:847-854.
123. Gambaryan AS, Tuzikov AB, Chinarev AA, etal. Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection. Antiviral Res. 2002;55:201-205.
124. Watanabe Y, Hashimoto Y, Shiratsuchi A, etal. Augmentation of fatality of influenza in mice by inhibition of phagocytosis. Biochem Biophys Res Commun. 2005;337:881-886.
125. Watanabe Y, Shiratsuchi A, Shimizu K, etal. Stimulation of phagocytosis of influenza virus-infected cells through surface desialylation of macrophages by viral neuraminidase. Microbiol Immunol. 2004;48:875-881.
126. Ukkonen P, Varis K, Jernfors M, etal. Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial. Lancet. 2000;356:1398-1402.
127. Johansson SM, Arnberg N, Elofsson M, etal. Multivalent HSA conjugates of 3′-sialyllactose are potent inhibitors of adenoviral cell attachment and infection. Chembiochem. 2005;6:358-364.
128. Hendricks GL, Weirich KL, Viswanathan K, etal. Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus. J Biol Chem. 2013;288:8061-8073.
129. Fievre S, Wieruszeski JM, Michalski JC, etal. Primary structure of a trisialylated oligosaccharide from human milk. Biochem Biophys Res Commun. 1991;177:720-725.
130. Yabe U, Sato C, Matsuda T, etal. Polysialic acid in human milk. CD36 is a new member of mammalian polysialic acid-containing glycoprotein. J Biol Chem. 2003;278:13875-13880.
131. Gamblin SJ, Skehel JJ. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem. 2010;285:28403-28409.
132. Matsubara T, Onishi A, Saito T, etal. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy. J Med Chem. 2010;53:4441-4449.
133. Ogata M, Murata T, Murakami K, etal. Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses. Bioorg Med Chem. 2007;15:1383-1393.
134. Zenhom M, Hyder A, de Vrese M, etal. Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARγ and peptidoglycan recognition protein 3. J Nutr. 2011;141:971-977.
135. Zenhom M, Hyder A, Kraus-Stojanowic I, etal. PPARγ-dependent peptidoglycan recognition protein 3 (PGlyRP3) expression regulates proinflammatory cytokines by microbial and dietary fatty acids. Immunobiology. 2011;216:715-724.
136. Eiwegger T, Stahl B, Haidl P, etal. Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr Allergy Immunol. 2010;21:1179-1188.
137. Comstock SS, Wang M, Hester SN, etal. Select human milk oligosaccharides directly modulate peripheral blood mononuclear cells isolated from 10-d-old pigs. Br J Nutr. 2014;111:819-828.
138. Bohm S, Schwab I, Lux A, etal. The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin Immunopathol. 2012;34:443-453.
139. Videira PA, Amado IF, Crespo HJ, etal. Surface α2-3- and α2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. Glycoconj J. 2008;25:259-268.
140. Cabral MG, Silva Z, Ligeiro D, etal. The phagocytic capacity and immunological potency of human dendritic cells is improved by α2, 6-sialic acid deficiency. Immunology. 2013;138:235-245.
141. Redelinghuys P, Antonopoulos A, Liu Y, etal. Early murine T-lymphocyte activation is accompanied by a switch from N-glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E. J Biol Chem. 2011;286:34522-34532.
142. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol. 2007;7:255-266.
143. Pillai S, Netravali IA, Cariappa A, etal. Siglecs and immune regulation. Annu Rev Immunol. 2012;30:357-392.
144. Benchimol EI, Fortinsky KJ, Gozdyra P, etal. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17:423-439.
145. Fuhrer A, Sprenger N, Kurakevich E, etal. Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J Exp Med. 2010;207:2843-2854.
146. Weiss GA, Hennet T. The role of milk sialyllactose in intestinal bacterial colonization. Adv Nutr. 2012;3:483S-488S.
147. + cells through TLR4. Proc Natl Acad Sci U S A. 2013;110:17444-17449.
148. Barclay AR, Russell RK, Wilson ML, etal. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr. 2009;155:421-426.
149. De Leoz ML, Gaerlan SC, Strum JS, etal. Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. J Proteome Res. 2012;11:4662-4672.
150. Jantscher-Krenn E, Zherebtsov M, Nissan C, etal. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut. 2012;61:1417-1425.
151. Miller JB, McVeagh P. Human milk oligosaccharides: 130 reasons to breast-feed. Br J Nutr. 1999;82:333-335.
152. Nohle U, Schauer R. Uptake, metabolism and excretion of orally and intravenously administered, 14C- and 3H-labeled N-acetylneuraminic acid mixture in the mouse and rat. Hoppe Seylers Z Physiol Chem. 1981;362:1495-1506.
153. Carlson SE, House SG. Oral and intraperitoneal administration of N-acetylneuraminic acid: effect on rat cerebral and cerebellar N-acetylneuraminic acid. J Nutr. 1986;116:881-886.
154. Morgan BL, Oppenheimer J, Winick M. Effects of essential fatty acid deficiency during late gestation on brain N-acetylneuraminic acid metabolism and behaviour in the progeny. Br J Nutr. 1981;46:223-230.
155. Morgan BL, Winick M. Effects of environmental stimulation on brain N-acetylneuraminic acid content and behavior. J Nutr. 1980;110:425-432.
156. Morgan BL, Winick M. Effects of administration of N-acetylneuraminic acid (NANA) on brain NANA content and behavior. J Nutr. 1980;110:416-424.
157. Morgan BL, Winick M. The subcellular localization of administered N-acetylneuraminic acid in the brains of well-fed and protein restricted rats. Br J Nutr. 1981;46:231-238.
158. Anderson JW, Johnstone BM, Remley DT. Breast-feeding and cognitive development: a meta-analysis. Am J Clin Nutr. 1999;70:525-535.
159. Hiratsuka S, Honma H, Saitoh Y, etal. Effects of dietary sialic acid in n-3 fatty acid-deficient dams during pregnancy and lactation on the learning abilities of their pups after weaning. J Nutr Sci Vitaminol (Tokyo). 2013;59:136-143.
160. Scholtz SA, Gottipati BS, Gajewski BJ, etal. Dietary sialic acid and cholesterol influence cortical composition in developing rats. J Nutr. 2013;143:132-135.
161. Sprenger N, Julita M, Donnicola D, etal. Sialic acid feeding aged rats rejuvenates stimulated salivation and colon enteric neuron chemotypes. Glycobiology. 2009;19:1492-1502.
162. Sakai F, Ikeuchi F, Urashima T, etal. Effects of feeding sialyllactose and galactosylated N-acetylneuraminic acid on swimming learning ability and brain lipid composition in adult rats. J Appl Glycosci. 2006;53:249-254.
163. Wang B, Downing JA, Petocz P, etal. Metabolic fate of intravenously administered N-acetylneuraminic acid-6-14-C in newborn piglets. Asia Pac J Clin Nutr. 2007;16:110-115.
164. Colombo JP, Garcia-Rodenas C, Guesry PR, etal. Potential effects of supplementation with amino acids, choline or sialic acid on cognitive development in young infants. Acta Paediatr Suppl. 2003;92:42-46.
165. Marques TM, Wall R, Ross RP, etal. Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol. 2010;21:149-156.
166. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012;22:1147-1162.
167. Han NS, Kim TJ, Park YC, etal. Biotechnological production of human milk oligosaccharides. Biotechnol Adv. 2012;30:1268-1278.
168. Strum JS, Aldredge D, Barile D, etal. Coupling flash liquid chromatography with mass spectrometry for enrichment and isolation of milk oligosaccharides for functional studies. Anal Biochem. 2012;424:87-96.
169. Choi YH, Kim JH, Park JH, etal. Protein engineering of α2, 3/2, 6-sialyltransferase to improve the yield and productivity of in vitro sialyllactose synthesis. Glycobiology. 2014;24:159-169.